B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 49.36 CNY -7.04% Market Closed
Market Cap: 20.7B CNY
Have any thoughts about
Betta Pharmaceuticals Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Betta Pharmaceuticals Co Ltd

Wall Street analysts forecast Betta Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Betta Pharmaceuticals Co Ltd is 51.71 CNY with a low forecast of 41.81 CNY and a high forecast of 63 CNY.

Lowest
Price Target
41.81 CNY
15% Downside
Average
Price Target
51.71 CNY
5% Upside
Highest
Price Target
63 CNY
28% Upside
Betta Pharmaceuticals Co Ltd Competitors:
Price Targets
4554
Fuji Pharma Co Ltd
39% Upside
605116
Aurisco Pharmaceutical Co Ltd
49% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
53% Upside
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
42% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
24% Upside
GLS
Glenmark Life Sciences Ltd
5% Upside
600285
Henan Lingrui Pharmaceutical Co Ltd
47% Upside

Revenue
Forecast

Revenue Estimate
Betta Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's revenue is 13%. The projected CAGR for the next 3 years is 24%.

13%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Betta Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's operating income is -1%. The projected CAGR for the next 3 years is 60%.

-1%
Past Growth
60%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Betta Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 37%.

0%
Past Growth
37%
Estimated Growth
Estimates Accuracy
-14%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Betta Pharmaceuticals Co Ltd's stock price target?
Price Target
51.71 CNY

According to Wall Street analysts, the average 1-year price target for Betta Pharmaceuticals Co Ltd is 51.71 CNY with a low forecast of 41.81 CNY and a high forecast of 63 CNY.

What is Betta Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's revenue is 13%. The projected CAGR for the next 3 years is 24%.

What is Betta Pharmaceuticals Co Ltd's Operating Income forecast?
Projected CAGR
60%

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's operating income is -1%. The projected CAGR for the next 3 years is 60%.

What is Betta Pharmaceuticals Co Ltd's Net Income forecast?
Projected CAGR
37%

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 37%.

Back to Top